Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
mBio ; 13(3): e0031122, 2022 06 28.
Article in English | MEDLINE | ID: covidwho-1807324

ABSTRACT

Population genomic analysis is a powerful tool to understand the evolutionary history of pathogens and the factors contributing to the success or failure of lineages. These studies have significant implications for human health, as evident from our ongoing tracking of SARS-CoV-2. In their article, Gill et al. (J. L. Gill, J. Hedge, D. J. Wilson, and R. C. MacLean, mBio 12:e02168-21, 2021, https://doi.org/10.1128/mBio.02168-21) demonstrate the utility of pathogen genomic data by comprehensively elucidating the origin of methicillin-resistant Staphylococcus aureus ST239. To accomplish this, they leveraged newly developed tools for querying large genomic data sets. Overall, these analyses rely on the availability of representative genomic data along with their associated metadata-information about where and when samples were collected, clinical and epidemiological characteristics, and phenotypic properties. However, in many instances, these data are missing. Here, I borrow the term "meaningful use" from the Health IT field to describe the need to maximize the utility of genomic data and make suggestions for how to address the current limitations.


Subject(s)
COVID-19 , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Biological Evolution , Genomics , Humans , Methicillin-Resistant Staphylococcus aureus/genetics , SARS-CoV-2/genetics , Staphylococcal Infections/epidemiology
2.
Viruses ; 14(4)2022 04 06.
Article in English | MEDLINE | ID: covidwho-1776364

ABSTRACT

SARS-CoV-2, the causative agent of COVID-19, emerged in late 2019. The highly contagious B.1.617.2 (Delta) variant of concern (VOC) was first identified in October 2020 in India and subsequently disseminated worldwide, later becoming the dominant lineage in the US. Understanding the local transmission dynamics of early SARS-CoV-2 introductions may inform actionable mitigation efforts during subsequent pandemic waves. Yet, despite considerable genomic analysis of SARS-CoV-2 in the US, several gaps remain. Here, we explore the early emergence of the Delta variant in Florida, US using phylogenetic analysis of representative Florida and globally sampled genomes. We find multiple independent introductions into Florida primarily from North America and Europe, with a minority originating from Asia. These introductions led to three distinct clades that demonstrated varying relative rates of transmission and possessed five distinct substitutions that were 3-21 times more prevalent in the Florida sample as compared to the global sample. Our results underscore the benefits of routine viral genomic surveillance to monitor epidemic spread and support the need for more comprehensive genomic epidemiology studies of emerging variants. In addition, we provide a model of epidemic spread of newly emerging VOCs that can inform future public health responses.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/epidemiology , Florida/epidemiology , Humans , Mutation , Phylogeny , SARS-CoV-2/genetics
3.
Commun Biol ; 4(1): 489, 2021 04 21.
Article in English | MEDLINE | ID: covidwho-1387493

ABSTRACT

We investigated SARS-CoV-2 transmission dynamics in Italy, one of the countries hit hardest by the pandemic, using phylodynamic analysis of viral genetic and epidemiological data. We observed the co-circulation of multiple SARS-CoV-2 lineages over time, which were linked to multiple importations and characterized by large transmission clusters concomitant with a high number of infections. Subsequent implementation of a three-phase nationwide lockdown strategy greatly reduced infection numbers and hospitalizations. Yet we present evidence of sustained viral spread among sporadic clusters acting as "hidden reservoirs" during summer 2020. Mathematical modelling shows that increased mobility among residents eventually catalyzed the coalescence of such clusters, thus driving up the number of infections and initiating a new epidemic wave. Our results suggest that the efficacy of public health interventions is, ultimately, limited by the size and structure of epidemic reservoirs, which may warrant prioritization during vaccine deployment.


Subject(s)
COVID-19/transmission , Communicable Disease Control/methods , Genome, Viral/genetics , Mutation , Public Health/methods , SARS-CoV-2/genetics , COVID-19/epidemiology , COVID-19/virology , Geography , Humans , Italy/epidemiology , Pandemics , Phylogeny , Public Health/trends , SARS-CoV-2/classification , SARS-CoV-2/physiology
SELECTION OF CITATIONS
SEARCH DETAIL